Deciphering the Enigma: A Comprehensive Approach to Unexplained Weight Loss in Clinical Practice
OthersPage Navigation
Introduction
Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six-month period, poses a diagnostic challenge in clinical practice. While it can be a harbinger of serious underlying pathology, it often remains unexplained despite thorough investigation.
Etiology and Clinical Evaluation
UWL can be attributed to gastrointestinal disorders, malignancies, psychiatric conditions, endocrine disorders, or chronic infections. The initial evaluation should include a comprehensive history, physical examination, and basic laboratory tests. If these are inconclusive, further targeted investigations may be required based on the patient's history and clinical presentation.
Role of Imaging and Specialized Tests
Imaging studies, such as CT scans or MRIs, can be useful in detecting occult malignancies or other abnormalities. Specialized tests, such as endoscopy or colonoscopy, may be warranted in cases of suspected gastrointestinal disorders. However, these should be guided by the patient's symptoms and risk factors, to avoid unnecessary investigations.
Management and Follow-Up
Management depends on the underlying cause. Even if no cause is identified, it is important to monitor the patient closely, as the cause may become apparent over time. Nutritional support should be provided to all patients experiencing UWL, to prevent further weight loss and associated complications.
Conclusion
UWL is a complex clinical problem that requires a systematic approach for effective management. While it can be frustrating when no cause is found, clinicians should remain vigilant, as early detection of serious underlying conditions can significantly impact patient outcomes.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge